VIJAYA DIAGNOSTIC CENTRE LIMITED Vijaya Diagnostic Centre Limited Share Price
Equities
VIJAYA
INE043W01024
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 808 INR | +4.09% |
|
+0.63% | +19.57% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 5.48B 65.8M | Sales 2025 * | 6.79B 81.52M | Capitalization | 82.83B 995M |
|---|---|---|---|---|---|
| Net income 2024 | 1.19B 14.27M | Net income 2025 * | 1.52B 18.23M | EV / Sales 2024 | 11.9 x |
| Net cash position 2024 * | 1.71B 20.51M | Net cash position 2025 * | 1.97B 23.71M | EV / Sales 2025 * | 11.9 x |
| P/E ratio 2024 |
54.9
x | P/E ratio 2025 * |
54.4
x | Employees | 1,996 |
| Yield 2024 * |
0.18% | Yield 2025 * |
0.19% | Free-Float | 46.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Vijaya Diagnostic Centre Limited
| 1 day | +4.09% | ||
| 1 week | +0.63% | ||
| Current month | +15.53% | ||
| 1 month | +20.08% | ||
| 3 months | +27.49% | ||
| 6 months | +35.28% | ||
| Current year | +19.57% |
1 week
750.60
837.95
1 month
652.45837.95
Current year
596.05837.95
1 year
369.45837.95
3 years
295.00837.95
5 years
295.00837.95
10 years
295.00837.95
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 42 | 05/02/05 | |
| Director of Finance/CFO | - | 01/21/01 | |
Sheshadri Vasan
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 57 | 26/21/26 | |
| Founder | 75 | 01/81/01 | |
| Director/Board Member | 48 | 05/02/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/24/18 | 808 | +4.09% | 57,698 |
| 17/24/17 | 776.2 | -1.10% | 237,032 |
| 16/24/16 | 784.8 | -2.18% | 396,287 |
| 15/24/15 | 802.4 | +5.52% | 2,870,124 |
| 14/24/14 | 760.4 | -0.66% | 400,216 |
Delayed Quote NSE India S.E., May 18, 2024 at 12:45 pm IST
More quotes
Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The Company operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The Company also offers a range of health and wellness packages to its customers as per their requirements. It operates approximately 121 diagnostic centers and 17 reference laboratories in 20 cities spread across India.
Calendar
07/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
808
INR
Average target price
750.6
INR
Spread / Average Target
-7.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.57% | 994M | |
| -17.05% | 8.55B | |
| +65.23% | 4.24B | |
| -1.63% | 2.53B | |
| -9.81% | 2.44B | |
| -41.76% | 2.35B | |
| -8.53% | 1.89B | |
| -19.29% | 1.55B | |
| -39.61% | 1.23B | |
| +9.68% | 1.13B |
- Stock Market
- Equities
- VIJAYA Stock
